Characterization of immune escape viruses from a macaque immunized with live-virus vaccine and challenged with pathogenic SHIV(KU-1)

AIDS Research and Human Retroviruses

Volumn 16, Issue 15, 2000, Pages 1573-1580

  Stipp, H L ^a   Kumar, A ^a   Narayan, O ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; MACACA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; VIROGENESIS; VIRUS LOAD;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; DNA, VIRAL; GENE PRODUCTS, NEF; GENE PRODUCTS, VPU; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MACACA; MOLECULAR SEQUENCE DATA; MUTAGENESIS; NEUTRALIZATION TESTS; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIRAL LOAD; VIRAL VACCINES;

EID: 0034633780     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200750006092     Document Type: Article

References (52)

1. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
2. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
3. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection
4. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Differential CTL responses to HIV-1 and Epstein-Barr virus in late disease
5. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans
6. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells
7. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics
8. CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic funciton despite the loss of human immunodeficiency virus-specific cytotoxicily
9. T cell responses and viral escape
10. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
11. Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses
12. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection
13. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition
14. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression
15. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo
16. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection
17. Cytotoxic T-lymphocyte escape viral variants: How important are they in viral evasion of immune clearance in vivo?
18. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
19. Escape of human immunodeficiency virus from immune control
20. Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads
21. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection
22. The HIV-1 V3 domain on field isolates: Participation in generation of escape virus in vivo and accessibility to neutralizing antibodies
23. Neutralizing antibody response during human immunodeficiency virus type 1 infection: Type and group specificity and viral escape
24. Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors
25. Envelope sequence variation, neutralizing antibodies, and primate lentivirus persistence
26. V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1
27. Persistent infection of macaques with simian-human immunodeficiency viruses
28. Characterization of HIV-1 neutralization escape mutants
29. Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes
30. Chimeric SHIV that causes CD4+ T cell loss and AIDS in rhesus macaques
31. Acute effects of pathogenic simian-human immunodeficiency virus challenge on vaccine-induced cellular and humoral immune responses to Gag in rhesus macaques
32. Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques
33. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an ADS-like disease after in vivo passage in rhesus monkeys
34. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys
35. Characterization of a neutralization-escape variant of SHIVKU-1, a virus that causes acquired immune deficiency syndrome in pig-tailed macaques
36. Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation
37. Oral immunization of macaques with attenuated vaccine virus induces proteciton against vaginally transmitted AIDS
38. General principles underlying laboratory diagnosis of viral and rickettsial infections
39. + T cell clones as stimulators and targets for assessment of CTL responses in macaque/AIDS model
40. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection
41. Glycosylation affects both the three-dimensional structure and antibody binding properties of the HIV-1IIIB GP120 peptide RP135
42. Effect of changes in the glycosylation of the human immunodeficiency virus type 1 envelope on the immunoreactivity and sensitivity to thrombin of its third variable domain
43. A role for carbohydrates in immune evasion in AIDS
44. Characterization of simian-human immunodeficiency virus envelope glycoprotein epitopes recognized by neutralizing antibodies from infected monkeys
45. The simian immunodeficiency virus envelope glycoprotein contains two epitopes presented by the Mamu-A*01 class I molecule
46. A MHC class I B locus allele-restricted simian immunodeficiency virus envelope CTL epitope in rhesus monkeys
47. A simian immunodeficiency virus envelope V3 cytotoxic T-lymphocyte epitope in rhesus monkeys and its restricting major histocompatibility complex class I molecule Mamu-A*02
48. Use of major histocompatibility complex class I/peptide/beta2M tetramers to quantitate CD8(+) cytotoxic T lymphocytes specific for dominant and non-dominant viral epitopes in simian-human immunodeficiency virus-infected rhesus monkeys
49. Definition of human immunodeficiency virus type 1 gp 120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major hostocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys
50. The CD8 + T lymphocyte response during primary SIVmac infection
51. Protection from pathogenic SIV challenge using multigenic DNA vaccines
52. A cell-free stock of simian-human immunodeficiency virus that causes AIDS in pigtailed macaques has a limited number of amino acid substitutions in both SIV(mac) and HIV-1 regions of the genome and has offered cytotropism